Insider Trading activities of Loxo Oncology, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Loxo Oncology, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Loxo Oncology, Inc. since year 2005. Table 2 shows the detailed insider transactions of Loxo Oncology, Inc. since 2005. The reporting company's ticker symbol is LOXO. The reporting company's CIK number is 1581720.
The total value of stock buying since 2005 is $95,767,003.
The total value of stock sales since 2005 is $31,368,749.
The total value of stock option exercises since 2005 is $329,619.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Loxo Oncology, Inc. (LOXO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 5,000 $450,000 0 $0
2017-09 0 $0 29,782 $2,662,239 19,782 $48,297
2017-08 0 $0 37,032 $2,733,739 19,782 $48,297
2017-05 0 $0 7,250 $330,186 0 $0
2017-01 160,000 $4,960,000 0 $0 0 $0
2016-12 0 $0 7,250 $219,167 0 $0
2016-09 0 $0 14,500 $435,000 0 $0
2016-08 0 $0 910,714 $24,538,418 0 $0
2016-05 232,558 $4,999,997 0 $0 0 $0
2015-12 200 $5,500 0 $0 0 $0
2015-11 347,442 $9,297,482 0 $0 0 $0
2015-04 0 $0 0 $0 43,217 $233,025
2014-08 5,652,731 $73,504,027 0 $0 0 $0
2013-08 230,769 $2,999,997 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Loxo Oncology, Inc. insiders (LOXO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-16 Naider Avi Z. Sale 5,000 90.00 450,000
2017-09-19 Van Naarden Jacob (Chief Business Officer) Sale 1,541 88.93 137,045
2017-09-19 Van Naarden Jacob (Chief Business Officer) Option Ex 1,541 3.65 5,621
2017-09-19 Bilenker Joshua H. (President & CEO) Sale 7,500 88.78 665,812
2017-09-19 Bilenker Joshua H. (President & CEO) Option Ex 7,500 1.18 8,880
2017-09-18 Van Naarden Jacob (Chief Business Officer) Sale 1,541 89.11 137,318
2017-09-18 Van Naarden Jacob (Chief Business Officer) Option Ex 1,541 3.65 5,621
2017-09-18 Burstein Jennifer (Vice President of Finance) Sale 1,700 89.32 151,842
2017-09-18 Burstein Jennifer (Vice President of Finance) Option Ex 1,700 11.35 19,295
2017-09-18 Bilenker Joshua H. (President & CEO) Sale 7,500 89.36 670,222
2017-09-18 Bilenker Joshua H. (President & CEO) Option Ex 7,500 1.18 8,880
2017-09-18 Naider Avi Z. Sale 5,000 90.00 450,000
2017-09-13 Naider Avi Z. Sale 5,000 90.00 450,000
2017-08-22 Kunkel Lori Anne Sale 10,000 75.17 751,730
2017-08-21 Flaherty Keith T. Sale 7,250 72.28 524,015
2017-08-15 Van Naarden Jacob (Chief Business Officer) Sale 1,541 73.42 113,134
2017-08-15 Van Naarden Jacob (Chief Business Officer) Option Ex 1,541 3.65 5,621
2017-08-15 Bilenker Joshua H. (President & CEO) Sale 7,500 73.58 551,865
2017-08-15 Bilenker Joshua H. (President & CEO) Option Ex 7,500 1.18 8,880
2017-08-14 Van Naarden Jacob (Chief Business Officer) Sale 1,541 73.81 113,741
2017-08-14 Van Naarden Jacob (Chief Business Officer) Option Ex 1,541 3.65 5,621
2017-08-14 Burstein Jennifer (Vice President of Finance) Sale 1,700 73.83 125,514
2017-08-14 Burstein Jennifer (Vice President of Finance) Option Ex 1,700 11.35 19,295
2017-08-14 Bilenker Joshua H. (President & CEO) Sale 7,500 73.83 553,740
2017-08-14 Bilenker Joshua H. (President & CEO) Option Ex 7,500 1.18 8,880
2017-05-22 Flaherty Keith T. Sale 7,250 45.54 330,186
2017-01-10 Purcell Dennis J Buy 160,000 31.00 4,960,000
2016-12-19 Flaherty Keith T. Sale 7,250 30.23 219,167
2016-09-07 Flaherty Keith T. Sale 14,500 30.00 435,000
2016-08-11 Flaherty Keith T. Sale 15,000 26.00 389,970
2016-08-10 Bonita David P Sale 447,857 26.96 12,074,224
2016-08-10 Isaly Samuel D Sale 447,857 26.96 12,074,224
2016-05-17 Purcell Dennis J Buy 232,558 21.50 4,999,997
2015-12-11 Purcell Dennis J Buy 200 27.50 5,500
2015-11-17 Naider Avi Z. Buy 3,773 26.50 99,984
2015-11-17 Purcell Dennis J Buy 265,000 26.50 7,022,500
2015-11-13 Purcell Dennis J Buy 1,955 27.47 53,703
2015-11-12 Purcell Dennis J Buy 76,714 27.65 2,121,295
2015-04-02 Goldstein Dov A Md (CFO and Treasurer) Option Ex 4,005 5.39 21,594
2015-04-01 Goldstein Dov A Md (CFO and Treasurer) Option Ex 39,212 5.39 211,431
2014-08-06 Naider Avi Z. Buy 3,846 13.00 49,998
2014-08-06 Bonita David P Buy 275,385 13.00 3,580,005
2014-08-06 Deerfield International Master Fund, L.p. Buy 1,089,656 13.02 14,184,052
2014-08-06 Florence Anthony A. Jr. (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Sonsini Peter W. (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Viswanathan Ravi (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Weller Harry R (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Drant Ryan D (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Purcell Dennis J Buy 413,077 13.00 5,370,001
2014-08-06 Baskett Forest (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Kolluri Krishna Kittu (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Elms Steve Buy 413,077 13.00 5,370,001
2014-08-06 Sandell Scott D (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Kerins Patrick J (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Mott David M (10% Owner) Buy 230,769 13.00 2,999,997
2014-08-06 Barrett M James (Director) Buy 230,769 13.00 2,999,997
2014-08-06 Goldstein Dov A Md (CFO and Treasurer) Buy 413,077 13.00 5,370,001
2014-08-06 Isaly Samuel D Buy 275,385 13.00 3,580,005
2014-08-06 Barris Peter J (10% Owner) Buy 230,769 13.00 2,999,997
2013-08-06 Nea 14 Gp, Ltd (10% Owner) Buy 230,769 13.00 2,999,997

Insider trading activities including stock purchases, stock sales, and option exercises of LOXO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Loxo Oncology, Inc. (symbol LOXO, CIK number 1581720) see the Securities and Exchange Commission (SEC) website.